Growth Metrics

Albemarle (ALB-PA) Cash & Equivalents (2016 - 2025)

Albemarle's Cash & Equivalents history spans 17 years, with the latest figure at $1.6 billion for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 35.71% year-over-year to $1.6 billion; the TTM value through Dec 2025 reached $1.6 billion, up 35.71%, while the annual FY2025 figure was $1.6 billion, 35.71% up from the prior year.
  • Cash & Equivalents reached $1.6 billion in Q4 2025 per ALB-PA's latest filing, down from $1.9 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $2.1 billion in Q1 2024 to a low of $439.3 million in Q4 2021.
  • Average Cash & Equivalents over 5 years is $1.3 billion, with a median of $1.5 billion recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: crashed 41.17% in 2021, then surged 242.47% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $439.3 million in 2021, then skyrocketed by 241.28% to $1.5 billion in 2022, then crashed by 40.64% to $889.9 million in 2023, then surged by 33.97% to $1.2 billion in 2024, then skyrocketed by 35.71% to $1.6 billion in 2025.
  • Per Business Quant, the three most recent readings for ALB-PA's Cash & Equivalents are $1.6 billion (Q4 2025), $1.9 billion (Q3 2025), and $1.8 billion (Q2 2025).